RELITREN-E 200MG INJECTION

Relitren-E 200mg Injection contains Trenbolone Enanthate 200mg/ml, a long-acting injectable trenbolone formulation. Trenbolone is not approved for human use in many countries and is primarily intended for veterinary use in some jurisdictions. Any non-medical use carries significant health risks and should only occur where legally permitted and under appropriate professional supervision.

As a trusted pharmaceutical exporter from India, we supply Relitren-E 200mg Injection manufactured in WHO-GMP compliant facilities with export-quality packaging and international shipping support. We cater to licensed importers, distributors, veterinary suppliers, and authorized pharmaceutical businesses, ensuring high-quality manufacturing, competitive pricing, and complete export documentation.

Product Highlights

• Contains Trenbolone Enanthate 200mg/ml
• Long-acting injectable formulation
• Manufactured under WHO-GMP quality standards
• Export-grade packaging for international markets
• Available for bulk supply and global export
• Complete export documentation and worldwide shipping